Geir Bjørklund

Medical Writer & Scientific Advisor

  • Home
  • About
  • Services
    • Medical Writing
    • Regulatory Communication
    • Evidence Synthesis & Scientific Advisory
    • Environmental & Toxicology Assessment
    • Executive & Stakeholder Communication
  • Industries
    • Pharma
    • Biotech
    • Medtech
    • Nutrition
    • Environmental Health
    • Investors
  • Case Studies
  • Publications
  • Engagement
  • Ethics
  • Contact
You are here: Home / Industries

Industries

Assignments support organisations that operate in regulated and science-driven domains where precision, traceability, and clear decision material are essential. Work is delivered in English and integrates smoothly with clinical development, regulatory affairs, medical affairs, R&D, corporate strategy, portfolio management, investor relations, legal, and corporate communications.

Pharmaceutical and biotechnology companies engage services for clinical and non-clinical documents, evidence reviews for programme decisions, regulatory briefing materials, and publication strategy. Deliverables align with ICH and good-practice expectations, harmonise terminology across modules, and maintain explicit links from narrative to tables, figures, and source data.

Nutrition and food technology firms request decision briefs on claims, targeted and systematic reviews, and technical memoranda on ingredients and formulations. Outputs map human and preclinical data to regulatory pathways, qualify claims with careful language, and provide auditable citation sets suitable for internal governance and external review.

Diagnostics and medical technology teams use support for clinical evidence summaries, performance and risk documentation, and publication-grade manuscripts. Materials translate study data into clear options for product teams and leadership, retaining scientific precision while remaining readable for cross-functional stakeholders.

Environmental health and safety units commission exposure characterisation and risk evaluations for chemicals and ingredients. Reports state assumptions, ranges, margins of safety, and uncertainty, with references to authoritative bodies and preserved calculation steps for verification by legal and corporate affairs.

Investors and corporate development groups engage scientific review during diligence. Work includes focused literature sweeps, structured assessment of efficacy and safety signals, method critiques, and decision notes that outline strengths, limitations, and implications for valuation or integration planning.

Projects are scoped to a defined question, a documented method, specified deliverables, and a disciplined review cycle. Draft one arrives on the agreed date with tracked changes and a comment log. A focused revision round is included to reach final approval. Source files and reference libraries are transferred at completion, and materials conform to document control and information security requirements.

For an initial proposal, share the objective, intended audience, due date, applicable standards, and confidentiality requirements. A written statement of work will set method, milestones, and price.

Copyright © 2025 Geir Bjørklund · Privacy Policy · Cookies · Accessibility · Contact